Better Outcomes With Early HETs in Pediatric-Onset MS

Source link :

Early treatment of pediatric-onset relapsing-remitting multiple sclerosis (MS) with high-efficacy therapy (HET) is associated with substantially slower disability progression than treatment with low-efficacy therapies or no treatment, new research suggested. An analysis of over 5000 people with MS onset between the ages of 15 and 24 years found the greatest benefit among those with minimal […]

Author : News Health

Publish date : 2024-04-02 10:41:12

Copyright for syndicated content belongs to the linked Source.